NL8303066A - Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten. - Google Patents

Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten. Download PDF

Info

Publication number
NL8303066A
NL8303066A NL8303066A NL8303066A NL8303066A NL 8303066 A NL8303066 A NL 8303066A NL 8303066 A NL8303066 A NL 8303066A NL 8303066 A NL8303066 A NL 8303066A NL 8303066 A NL8303066 A NL 8303066A
Authority
NL
Netherlands
Prior art keywords
group
formula
defined above
hydrogen atom
compound
Prior art date
Application number
NL8303066A
Other languages
English (en)
Dutch (nl)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15409082A external-priority patent/JPS5962585A/ja
Priority claimed from JP57213167A external-priority patent/JPS59104378A/ja
Priority claimed from JP58114679A external-priority patent/JPS606685A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL8303066A publication Critical patent/NL8303066A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NL8303066A 1982-09-03 1983-09-02 Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten. NL8303066A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP15409082A JPS5962585A (ja) 1982-09-03 1982-09-03 カルボスチリル誘導体
JP15409082 1982-09-03
JP21316782 1982-12-03
JP57213167A JPS59104378A (ja) 1982-12-03 1982-12-03 カルボスチリル誘導体
JP11467983 1983-06-24
JP58114679A JPS606685A (ja) 1983-06-24 1983-06-24 カルボスチリル誘導体

Publications (1)

Publication Number Publication Date
NL8303066A true NL8303066A (nl) 1984-04-02

Family

ID=27312797

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303066A NL8303066A (nl) 1982-09-03 1983-09-02 Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten.

Country Status (11)

Country Link
US (1) US4564619A (sv)
KR (1) KR910000181B1 (sv)
CA (1) CA1252469A (sv)
CH (1) CH655110A5 (sv)
DE (1) DE3331808A1 (sv)
ES (4) ES525346A0 (sv)
FR (1) FR2532648B1 (sv)
GB (1) GB2127402B (sv)
IT (1) IT1193145B (sv)
NL (1) NL8303066A (sv)
SE (1) SE455503B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851296B (sv) * 1984-05-29 1985-11-25 Pfizer
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
KR100305515B1 (ko) * 1999-02-04 2001-09-24 이순금 메주의 제조방법
NL1012886C1 (nl) * 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan.
KR100422242B1 (ko) * 2001-07-20 2004-03-12 농업회사법인(주)맛가마식품 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
EP1554267A1 (en) * 2002-10-07 2005-07-20 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
NL1028564C2 (nl) * 2005-03-17 2006-09-20 Rademaker Holding B V Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten.
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971797A (en) * 1973-06-15 1976-07-27 Merck & Co., Inc. S,S'-bis(pyridylmethyl)-carbonodithioates
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2659665A1 (de) * 1976-12-30 1978-07-13 Nattermann A & Cie Neue 1,4-dihydropyridin-derivate
JPS5387368A (en) * 1977-01-12 1978-08-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5390270A (en) * 1977-01-14 1978-08-08 Otsuka Pharmaceut Co Ltd Carbostryl derivs.
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
IT1097538B (it) * 1978-07-17 1985-08-31 Medea Res Srl Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts

Also Published As

Publication number Publication date
GB2127402B (en) 1987-01-14
DE3331808A1 (de) 1984-03-08
ES532537A0 (es) 1985-10-16
CA1252469A (en) 1989-04-11
IT8367922A0 (it) 1983-09-05
ES8502686A1 (es) 1985-01-16
GB8323542D0 (en) 1983-10-05
FR2532648B1 (fr) 1989-07-21
ES8506697A1 (es) 1985-07-16
SE8304737L (sv) 1984-03-04
KR910000181B1 (ko) 1991-01-21
FR2532648A1 (fr) 1984-03-09
IT1193145B (it) 1988-06-02
ES525346A0 (es) 1985-01-16
SE455503B (sv) 1988-07-18
ES532538A0 (es) 1985-07-16
SE8304737D0 (sv) 1983-09-02
KR850000402A (ko) 1985-02-27
CH655110A5 (de) 1986-03-27
US4564619A (en) 1986-01-14
ES8601187A1 (es) 1985-10-16
ES8505998A1 (es) 1985-06-16
ES532536A0 (es) 1985-06-16
GB2127402A (en) 1984-04-11

Similar Documents

Publication Publication Date Title
NL8303066A (nl) Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten.
US4707486A (en) Diaryl piperidine containing esters of 1,4-dihydropyridines and coronary therapeutic use
KR920005742B1 (ko) 약제학상 유용한 디하이드로피리디닐디카르복실레이트 아마이드 및 에스테르의 제조방법
JPS635024B2 (sv)
JPS6136273A (ja) 2−フエニルアルキル−4(3h)−キナゾリノン誘導体
EP0145010B1 (en) Carbostyril derivatives
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
US4948899A (en) 1,4-dihydropyridine derivatives
HU186583B (en) Process for producing new 2-bracket-substituted or free-bracket closed-amino-carbonyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
US5489585A (en) Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections
JPH0129794B2 (sv)
JPS6147477A (ja) 新規1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
FI62531B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart 3-yan-n-(n n-dimetylamino-propyl)-iminobensyl och syraaddit iossalter daerav
CA3106968A1 (en) Novel catechol derivatives or salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same
JPH054920A (ja) 降圧剤
CS273172B2 (en) Method of dihydropyridine derivatives production
EP0039919A1 (en) Benzoxazole and benzothiazole derivatives with anti-allergic activity
JPH05504345A (ja) 新規ジヒドロピリジン
TWI224099B (en) Benzopyran derivatives and antiallergic agent
JPH0378390B2 (sv)
EP0370821B1 (en) 1,4-dihydropyridine derivatives
JPH0368555A (ja) 1,4―ジヒドロピリジン誘導体、その製造方法及びこれを含有する心臓血管疾患又は高血圧治療剤
US4818766A (en) Novel phenoxyaliphatylphenyleneoxyalkyl esters and amides
JPH1129471A (ja) クマリン誘導体を薬効成分として含有する肝疾患治療剤
JPH0525115A (ja) アミド化合物およびその合成中間体

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed